Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE010 (ESP) (Dr. Silva)
· consented 2023-03-19
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Grade 2 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2023-04-11 (study day 12); relationship: Y
severe
assessed
2026-08-18
Grade 3 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-08-27 (study day 150); relationship: N
mild
assessed
2026-08-18
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-12-15 (study day 260); relationship: not assessed
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.